image:
Dr. Anne Rgnier-Vigouroux, coordinator of the GlioLighT project funded by the EU
Credit: : Anne Rgnier-Vigouroux
Gliomas are the most common type of brain tumors and are difficult to treat because they tend to be diffuse and are often located deep within the brain. A very promising and innovative technique for the therapy of gliomas will be investigated in a new EU project and should pave the way for clinical use. "We are convinced that our research will help to significantly improve the treatment of gliomas," said the coordinator of the project, Dr. Anne Rgnier-Vigouroux of Johannes Gutenberg University Mainz (JGU). The other project partners are Aston University in Birmingham, the University of Barcelona, LMU Munich, the Finnish laser manufacturer Modulight, and MODUS Research and Innovation Ltd., a British not-for-profit organization providing advice to secure research funding. Through its Pathfinder program, the European Innovation Council (EIC) supports the exploration of highly innovative and speculative new technologies at the very earliest phase of their development. The new GlioLighT project will receive funding of approximately EUR 2.2 million over the next three years.
Using extremely toxic singlet oxygen to combat gliomas
Gliomas are an extremely deadly form of cancer, mainly due to the inaccessibility of the brain and the widespread dissemination of the tumor cells. These diffuse cells are often anchored too deeply in the brain to be removed completely using current therapeutic techniques, such as resection, irradiation, or chemotherapy. A promising alternative to eliminate glioma cells is to generate reactive oxygen species (ROS) directly at the affected sites. Currently, ROS can only be produced through photodynamic therapy, which has been employed for decades but involves potentially toxic photosensitizers. To avoid detrimental side effects of this type of treatment, the GlioLighT partners propose a different approach involving direct light therapy. This method will entail the direct generation of ROS using laser light at a wavelength of 1,267 nanometers, which is in the near-infrared range. The irradiation of light will produce singlet oxygen, which destroys cancer cells.
"Assuming we can reach the tumor cells directly with laser light, we will no longer need photosensitizers as amplifiers. We will have a minimally invasive and selective procedure, representing a completely new strategy for glioma treatment," said Dr. Anne Rgnier-Vigouroux. The benefits of this approach include improved efficacy of treatment, earlier intervention, and reduced costs. Currently, the precise cancer-inhibiting mechanism of direct light therapy and the safety of the procedure itself are not well understood.
Janus-headed macrophages: Anti-inflammatory potential promotes tumor growth
The laser radiation will also affect the cells of the immune system which are expected to fight tumor cells. "We will be paying special attention to the effects on tumor cells but also on immune cells, particularly the macrophages," emphasized Rgnier-Vigouroux. Macrophages are scavenger cells that take up pathogens and render them harmless. They can trigger inflammatory reactions and thus contribute to the bodys immune response and the fight against tumor cells. However, they can also have anti-inflammatory activities and thus prevent other immune cells from attacking the tumor.
"Macrophages can kill tumor cells, but they can also be recruited and manipulated by them, resulting in tumor growth." It is this second possibility that Dr. Anne Rgnier-Vigouroux aims to prevent: "We need to eliminate the tumor cells and, at the same time, trigger the immune cells in their vicinity to exert toxic effects on them."
Other aspects that the GlioLighT researchers will investigate include the type of tumor cell death induced by the laser light, the effect of laser light exposure on healthy cells in the brain, such as the neurons, and the determination of a safe dosage that can be administered without harming healthy cells. The project partners will work on innovative ultrashort pulse lasers to optimize the optical penetration through tissue and to minimize potential risks, ensuring that direct light therapy is suitable for clinical application. Ultimately, the development of a preclinical GlioLighT delivery and sensing system (pcGlio-DSS) should improve glioma treatment.
EIC Pathfinder program provides support for visionary and high-risk technologies in their early stages of development
The GlioLighT Next Generation Glioma Treatments using Direct Light Therapy project is being financed through the future-oriented EIC Pathfinder program under the aegis of the European Union's Horizon Europe program. The EU will provide a total of EUR 2.2 million in financial support to the project, of which approximately EUR 770,000 is earmarked for the research to be undertaken at Johannes Gutenberg University Mainz. The purpose of the EIC Pathfinder Open program of the European Innovation Council is to identify radically new technologies that have the potential to create new markets. Grants are thus awarded to groundbreaking and highly speculative projects that are still in an early stage of development. The participants in a project that has been awarded EIC Pathfinder support are typically visionary and entrepreneurial-minded specialists and researchers at universities, research institutes, start-ups, high-tech SMEs, and individuals working in the industrial realm who have a particular interest in investigating and creating technological innovations.
Project coordinator Dr. Anne Rgnier-Vigouroux has been research group leader at JGU's Institute of Developmental Biology and Neurobiology since January 2013. Her group focuses on the study of cerebral anti-tumor immunity, particularly on the role of microglia and macrophages in brain tumor biology.
Related links:
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.
See original here:
EU funding for pioneering research on the treatment of gliomas - EurekAlert
- Close Encounters of Skin and Nerve Cells - The Scientist - April 15th, 2024 [April 15th, 2024]
- OrthoID: Decoding Cellular Conversations with Cutting-Edge Technology - yTech - April 15th, 2024 [April 15th, 2024]
- Impact of aldehydes on DNA damage and aging - EurekAlert - April 15th, 2024 [April 15th, 2024]
- Redefining Cell Biology: Nondestructive Genetic Insights With Raman Spectroscopy - SciTechDaily - March 29th, 2024 [March 29th, 2024]
- Scientists Unravel the Unusual Cell Biology Behind Toxic Algal Blooms - SciTechDaily - March 19th, 2024 [March 19th, 2024]
- Ancient retroviruses played a key role in the evolution of vertebrate brains - EurekAlert - February 21st, 2024 [February 21st, 2024]
- Singapore scientists uncover a crucial link between cholesterol synthesis and cancer progression - EurekAlert - February 4th, 2024 [February 4th, 2024]
- Scientists uncover a way to "hack" neurons' internal clocks to speed up brain cell development - News-Medical.Net - February 4th, 2024 [February 4th, 2024]
- First atomic-scale 'movie' of microtubules under construction, a key process for cell division - EurekAlert - February 4th, 2024 [February 4th, 2024]
- Small RNAs take on the big task of helping skin wounds heal better and faster with minimal scarring - EurekAlert - February 4th, 2024 [February 4th, 2024]
- Shengjie Feng channels the powers of cryogenic electron microscopy - Newswise - January 19th, 2024 [January 19th, 2024]
- Study pinpoints breast cancer cells-of-origi - EurekAlert - January 19th, 2024 [January 19th, 2024]
- New analysis of cancer cells identifies 370 targets for smarter, personalized treatments - News-Medical.Net - January 19th, 2024 [January 19th, 2024]
- The future of mRNA biology and AI convergence - Drug Target Review - December 22nd, 2023 [December 22nd, 2023]
- The future of artificial breast milk, according to one lab - Quartz - December 22nd, 2023 [December 22nd, 2023]
- Shedding new light on the hidden organization of the cytoplasm - News-Medical.Net - December 22nd, 2023 [December 22nd, 2023]
- Bugs that help bugs: How environmental microbes boost fruit fly reproduction - EurekAlert - December 22nd, 2023 [December 22nd, 2023]
- Cells Move in Groups Differently Than They Do When Alone - NYU Langone Health - December 14th, 2023 [December 14th, 2023]
- Cells move in groups differently than they do when alone - EurekAlert - December 14th, 2023 [December 14th, 2023]
- Seattle Hub for Synthetic Biology plans to transform cells into tiny recording devices - GeekWire - December 14th, 2023 [December 14th, 2023]
- Virginia Tech and Weizmann Institute of Science tackle cell ... - Virginia Tech - October 16th, 2023 [October 16th, 2023]
- Vast diversity of human brain cell types revealed in trove of new ... - Spectrum - Autism Research News - October 16th, 2023 [October 16th, 2023]
- Singamaneni to develop advanced protein imaging method - The ... - Washington University in St. Louis - October 16th, 2023 [October 16th, 2023]
- Researchers find certain cancers can activate 'enhancer' in the ... - University of Toronto - October 16th, 2023 [October 16th, 2023]
- 2023 Hettleman Prizes awarded to five exceptional early-career ... - UNC Research - October 16th, 2023 [October 16th, 2023]
- Faeth Therapeutics Announces National Academy of Medicine ... - BioSpace - October 16th, 2023 [October 16th, 2023]
- From Migrant Farm Worker to Duke Scientist, Everardo Macias ... - Duke University School of Medicine - October 16th, 2023 [October 16th, 2023]
- Finding the golden ticket? Cyclin T1 is required for HIV-1 latency ... - Fred Hutch News Service - October 16th, 2023 [October 16th, 2023]
- Spermidine May Improve Egg Health and Fertility - Lifespan.io News - October 16th, 2023 [October 16th, 2023]
- Molecule discovered that grows bigger and stronger muscles - Earth.com - October 16th, 2023 [October 16th, 2023]
- SGIOY: 3 Biotech Stocks With Potential Future Gains - StockNews.com - October 16th, 2023 [October 16th, 2023]
- Association for Molecular Pathology Publishes Best Practice ... - Technology Networks - October 16th, 2023 [October 16th, 2023]
- A new cell type with links to gastric cancer steps up for its mugshot - Fred Hutch News Service - October 16th, 2023 [October 16th, 2023]
- Programmed cell death may be 1.8 billion year - EurekAlert - October 16th, 2023 [October 16th, 2023]
- New study confirms presence of flesh-eating and illness-causing ... - Science Daily - October 16th, 2023 [October 16th, 2023]
- New Institute for Immunologic Intervention (3i) at the Hackensack ... - Hackensack Meridian Health - October 16th, 2023 [October 16th, 2023]
- Post-doctoral Fellow in Cancer Biology in the Department of ... - Times Higher Education - October 16th, 2023 [October 16th, 2023]
- Scientists uncover key enzymes involved in bacterial pathogenicity - News-Medical.Net - October 16th, 2023 [October 16th, 2023]
- B cell response after influenza vaccine in young and older adults - EurekAlert - October 16th, 2023 [October 16th, 2023]
- Post-doctoral researcher in yeast cell biology job with UNIVERSITY ... - Times Higher Education - April 8th, 2023 [April 8th, 2023]
- expert reaction to study looking at creating embryo-like structures ... - Science Media Centre - April 8th, 2023 [April 8th, 2023]
- UCF Bone Researcher Receives National Recognition - UCF - April 8th, 2023 [April 8th, 2023]
- PhenomeX to Participate in American Association of Cancer ... - BioSpace - April 8th, 2023 [April 8th, 2023]
- Inland Empire stem-cell therapy gets $2.9 million booster - UC Riverside - April 8th, 2023 [April 8th, 2023]
- New finding in roundworms upends classical thinking about animal cell differentiation - News-Medical.Net - April 8th, 2023 [April 8th, 2023]
- Biology's unsolved chicken-or-egg problem: Where did life come from? - Big Think - April 8th, 2023 [April 8th, 2023]
- Azacitidine in Combination With Trametinib May Be Effective for ... - The ASCO Post - April 8th, 2023 [April 8th, 2023]
- Researchers clear the way for well-rounded view of cellular defects - Phys.org - April 8th, 2023 [April 8th, 2023]
- We were dancing around the lab cellular identity discovery has potential to impact cancer treatments - Newswise - April 8th, 2023 [April 8th, 2023]
- Environmental stressors' effect on gene expression explored in lecture - Environmental Factor Newsletter - April 8th, 2023 [April 8th, 2023]
- RNA therapy restores gene function in monkeys modeling ... - Spectrum - Autism Research News - April 8th, 2023 [April 8th, 2023]
- Traumatic brain injury interferes with immune system cells' recycling ... - Science Daily - April 8th, 2023 [April 8th, 2023]
- Lab-grown fat could give cultured meat real flavor and texture - EurekAlert - April 8th, 2023 [April 8th, 2023]
- Researchers reveal mechanism of polarized cortex assembly in migrating cells - Phys.org - April 8th, 2023 [April 8th, 2023]
- Probing Selfish Centromeres Unveils an Evolutionary Arms Race - The Scientist - April 8th, 2023 [April 8th, 2023]
- Meet the 2023 Outstanding Graduating Students - UMaine News ... - University of Maine - April 8th, 2023 [April 8th, 2023]
- The Worlds Sexiest Fragrance Unveiled, But Its Not For You - Revyuh - April 8th, 2023 [April 8th, 2023]
- City of Hope appoints John D. Carpten, Ph.D., as director of its ... - BioSpace - April 8th, 2023 [April 8th, 2023]
- Modernized Algorithm Predicts Drug Targets for SARS-CoV-2, Other ... - GenomeWeb - April 8th, 2023 [April 8th, 2023]
- BU researcher wins $3.9 million NIH grant to develop novel therapeutic modalities for Alzheimer's - News-Medical.Net - April 8th, 2023 [April 8th, 2023]
- Providing critical insights for animal development - HKU biologists ... - EurekAlert - April 8th, 2023 [April 8th, 2023]
- Students Express Frustrations About the Middle Class Scholarship - The Triton - April 8th, 2023 [April 8th, 2023]
- Mendus redeems the outstanding convertible bonds from Negma ... - GlobeNewswire - April 8th, 2023 [April 8th, 2023]
- Sustainability in research: If you want to green your lab, start with the ... - McGill Reporter - April 8th, 2023 [April 8th, 2023]
- Two-organ chip to answer fatty liver questions - EurekAlert - April 8th, 2023 [April 8th, 2023]
- Blind dating in bacteria evolution - Newswise - April 8th, 2023 [April 8th, 2023]
- White blood cells play unexpected role in clearing out dead liver cells - EurekAlert - April 8th, 2023 [April 8th, 2023]
- Woolly mammoths evolved smaller ears and woolier coats over the 700,000 years that they roamed the Siberian steppes - Newswise - April 8th, 2023 [April 8th, 2023]
- Pathogen mapped: Evolution and potential treatments - Science Daily - March 31st, 2023 [March 31st, 2023]
- ProJenX Announces Formation of Scientific Advisory Board - Yahoo Finance - March 31st, 2023 [March 31st, 2023]
- Science journalist Rebecca Skloot to speak on 'The Immortal Life of ... - Virginia Tech Daily - March 31st, 2023 [March 31st, 2023]
- How cell mechanics influences everything | MIT News ... - MIT News - March 31st, 2023 [March 31st, 2023]
- Artificial Cells The Powerhouse of the Future - SciTechDaily - March 31st, 2023 [March 31st, 2023]
- Basic Science Experts and Information for Media - St. Jude ... - St. Jude Children's Research Hospital - March 31st, 2023 [March 31st, 2023]
- Mendus presents an update on the use of its DCOne platform to source high-quality NK cell therapies at the 8th Annual Innate Killer Summit - Yahoo... - March 31st, 2023 [March 31st, 2023]
- Researchers reveal structural basis of plp2-mediated cytoskeletal protein folding by TRiC/CCT - Phys.org - March 31st, 2023 [March 31st, 2023]
- Labroots Announces Full Agenda for its 5th Annual Bioprocessing ... - PR Web - March 31st, 2023 [March 31st, 2023]
- RoslinCT and Lykan Bioscience announce that the MHRA has granted an MIA License for their cGMP Manufacturing facilities in Edinburgh, UK - Yahoo... - March 31st, 2023 [March 31st, 2023]
- 'ASBMB opened the doors for me' - ASBMB Today - March 31st, 2023 [March 31st, 2023]
- More Fun Than Fun: Science Is Impoverished Without Its Tales - The Wire Science - March 31st, 2023 [March 31st, 2023]